« Previous
Next »
Titles
- A randomized trial testing the effect of narrative vignettes versus guideline summaries on provider response to a professional organization clinical policy for safe opioid prescribing1
- Adjusting for covariates in randomized clinical trials for drugs and biological products: guidance for industry1
- Anabolic therapies for osteoporosis in postmenopausal women: effectiveness and value : final evidence report1
- Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer: effectiveness and value : final evidence report1
- Coming soon?: the ongoing effort to promote better depression services in primary care1
- Controversies in migraine management: a technology assessment : final report1
- Controversies in the management of patients with type 2 diabetes: final report1
- Diagnostic tests for Alzheimer's disease: generating and evaluating evidence to inform insurance coverage policy1
- Disease-modifying therapies for relapsing-remitting and primary-progressive multiple sclerosis: effectiveness and value : final evidence report1
- Dupilumab and crisaborole for atopic dermatitis: effectiveness and value : final evidence report and meeting summary1
- Effect of financial incentives to physicians, patients, or both on lipid levels: a randomized clinical trial1
- Elagolix for treating endometriosis: final evidence report1
- Excluding older, sicker patients from clinical trials: issues, concerns, and solutions1
- Guided care: a structured approach to providing comprehensive primary care for complex patients1
- Navigating care transitions in California: two models for change1
- Obeticholic acid for the treatment of nonalcoholic steatohepatitis: comparative clinical effectiveness and value : evidence report1
- Obeticholic acid for the treatment of primary biliary cholangitis: comparative clinical effectiveness, value, and value-based price benchmarks : evidence report1
- PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks : final report1
- Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report1
- Proton beam therapy: final evidence report1